Intellia Therapeutics, Inc. - Common Stock (NTLA)
CUSIP: 45826J105
Q4 2017 13F Holders as of 31 Dec 2017
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 116,932,531
- Total 13F shares
- 24,300,186
- Share change
- +6,813,778
- Total reported value
- $467,047,800
- Put/Call ratio
- 75%
- Price per share
- $19.22
- Number of holders
- 110
- Value change
- +$127,200,241
- Number of buys
- 74
- Number of sells
- 26
Quarterly Holders Quick Answers
What is CUSIP 45826J105?
CUSIP 45826J105 identifies NTLA - Intellia Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 45826J105:
Top shareholders of NTLA - Intellia Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Atlas Venture Associates IX, LLC |
13F
|
Company |
3.1%
|
3,579,788
|
$88,958,000 | — | 30 Sep 2017 | |
| FMR LLC |
13F
|
Company |
2.7%
|
3,211,264
|
$79,800,000 | — | 30 Sep 2017 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
2.3%
|
2,662,180
|
$66,155,000 | — | 30 Sep 2017 | |
| BlackRock Finance, Inc. |
13F
|
Company |
1.4%
|
1,679,285
|
$41,730,000 | — | 30 Sep 2017 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.91%
|
1,062,120
|
$26,394,000 | — | 30 Sep 2017 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.89%
|
1,045,293
|
$25,976,000 | — | 30 Sep 2017 | |
| Temasek Holdings (Private) Ltd |
13F
|
Company |
0.68%
|
790,527
|
$19,645,000 | — | 30 Sep 2017 | |
| Global Thematic Partners, LLC |
13F
|
Company |
0.43%
|
502,327
|
$12,483,000 | — | 30 Sep 2017 | |
| ARK Investment Management LLC |
13F
|
Company |
0.32%
|
372,478
|
$9,256,000 | — | 30 Sep 2017 | |
| GMT CAPITAL CORP |
13F
|
Company |
0.28%
|
330,533
|
$8,214,000 | — | 30 Sep 2017 | |
| MORGAN STANLEY |
13F
|
Company |
0.25%
|
289,368
|
$7,190,000 | — | 30 Sep 2017 | |
| Granahan Investment Management, LLC |
13F
|
Company |
0.24%
|
286,144
|
$7,111,000 | — | 30 Sep 2017 | |
| STATE STREET CORP |
13F
|
Company |
0.16%
|
189,385
|
$4,708,000 | — | 30 Sep 2017 | |
| Artal Group S.A. |
13F
|
Company |
0.15%
|
175,000
|
$4,349,000 | — | 30 Sep 2017 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.13%
|
152,156
|
$3,781,000 | — | 30 Sep 2017 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.12%
|
137,514
|
$3,417,000 | — | 30 Sep 2017 | |
| UNITED SERVICES AUTOMOBILE ASSOCIATION |
13F
|
Company |
0.08%
|
92,700
|
$2,304,000 | — | 30 Sep 2017 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.06%
|
73,739
|
$1,832,000 | — | 30 Sep 2017 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.06%
|
73,100
|
$1,817,000 | — | 30 Sep 2017 | |
| UBS Group AG |
13F
|
Company |
0.06%
|
69,624
|
$1,730,000 | — | 30 Sep 2017 | |
| Neuberger Berman Group LLC |
13F
|
Company |
0.05%
|
60,915
|
$1,514,000 | — | 30 Sep 2017 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.05%
|
57,492
|
$1,429,000 | — | 30 Sep 2017 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.04%
|
43,409
|
$1,079,000 | — | 30 Sep 2017 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.04%
|
42,678
|
$1,061,000 | — | 30 Sep 2017 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.03%
|
38,465
|
$954,000 | — | 30 Sep 2017 | |
| TIAA CREF INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.03%
|
38,339
|
$953,000 | — | 30 Sep 2017 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.03%
|
35,848
|
$891,000 | — | 30 Sep 2017 | |
| MARTINGALE ASSET MANAGEMENT L P |
13F
|
Company |
0.03%
|
32,307
|
$803,000 | — | 30 Sep 2017 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.03%
|
31,964
|
$794,000 | — | 30 Sep 2017 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.02%
|
27,100
|
$673,000 | — | 30 Sep 2017 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.02%
|
26,418
|
$657,000 | — | 30 Sep 2017 | |
| TEACHERS ADVISORS, LLC |
13F
|
Company |
0.02%
|
26,094
|
$648,000 | — | 30 Sep 2017 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.02%
|
23,538
|
$585,000 | — | 30 Sep 2017 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.02%
|
23,343
|
$580,000 | — | 30 Sep 2017 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.02%
|
22,640
|
$563,000 | — | 30 Sep 2017 | |
| ProShare Advisors LLC |
13F
|
Company |
0.02%
|
21,315
|
$530,000 | — | 30 Sep 2017 | |
| Swiss National Bank |
13F
|
Company |
0.02%
|
20,700
|
$514,000 | — | 30 Sep 2017 | |
| Numeric Investors LLC |
13F
|
Company |
0.02%
|
20,434
|
$508,000 | — | 30 Sep 2017 | |
| MORGENS WATERFALL VINTIADIS & CO INC |
13F
|
Company |
0.02%
|
20,000
|
$497,000 | — | 30 Sep 2017 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.01%
|
17,456
|
$434,000 | — | 30 Sep 2017 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.01%
|
16,717
|
$415,000 | — | 30 Sep 2017 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.01%
|
14,010
|
$348,000 | — | 30 Sep 2017 | |
| PKO Investment Management Joint-Stock Co |
13F
|
Company |
0.01%
|
12,816
|
$318,477 | — | 30 Sep 2017 | |
| Moloney Securities Asset Management, LLC |
13F
|
Company |
0.01%
|
12,296
|
$306,000 | — | 30 Sep 2017 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.01%
|
12,262
|
$304,000 | — | 30 Sep 2017 | |
| M&T BANK CORP |
13F
|
Company |
0.01%
|
11,516
|
$286,000 | — | 30 Sep 2017 | |
| Creative Planning |
13F
|
Company |
0.01%
|
11,415
|
$284,000 | — | 30 Sep 2017 | |
| Commonwealth Equity Services, Inc |
13F
|
Company |
0.01%
|
11,296
|
$281,000 | — | 30 Sep 2017 | |
| SABBY MANAGEMENT, LLC |
13F
|
Company |
0.01%
|
11,281
|
$280,000 | — | 30 Sep 2017 | |
| METROPOLITAN LIFE INSURANCE CO/NY |
13F
|
Company |
0.01%
|
11,016
|
$274,000 | — | 30 Sep 2017 |
Institutional Holders of Intellia Therapeutics, Inc. - Common Stock (NTLA) as of Q4 2017
As of 31 Dec 2017,
Intellia Therapeutics, Inc. - Common Stock (NTLA) was held by
110 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,300,186 shares.
The largest 10 holders included
FMR LLC, Atlas Venture Associates IX, LLC, ORBIMED ADVISORS LLC, Vanguard Group Inc, BlackRock Inc., ARK Investment Management LLC, STATE STREET CORP, BAKER BROS. ADVISORS LP, FARALLON CAPITAL MANAGEMENT LLC, and Temasek Holdings (Private) Ltd.
This page lists
110
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2017 vs Q3 2017 Across Filers
Q3 2017 holders
84
Q4 2017 holders
110
Holder diff
26
| Investor | Q3 2017 Shares | Q4 2017 Shares | Share Diff | Share Chg % | Q3 2017 Value $ | Q4 2017 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.